Living donor cell infusion for kidney transplant recipients
Part of Immune system & allergy, Kidney & urinary clinical trials.
This trial tests a new way to help your body accept the transplanted kidney without needing as many strong anti-rejection drugs. It uses special cells from your living donor, which may lower the risk of rejection and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 69 years old and receiving your first kidney transplant.
- The kidney comes from a living donor (not a perfect genetic match) who is between 18 and 70 years old.
- Your donor agrees to have a special blood collection for cell preparation.
- You and your donor must not have certain infections or conditions (like tuberculosis), and you must pass standard donor screening.
- You are having only a kidney transplant (not another organ at the same time).
- You are willing to use birth control for 12 months after the cell infusion, if you are of childbearing age.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a special mix of donor immune cells along with immune-suppressing medicines right after a kidney transplant can help the body accept the new kidney without long-term anti-rejection drugs. It aims to reduce the need for daily transplant medications.
This trial tests a new liquid treatment (iCM012) that is applied to a donor kidney before transplantation. The goal is to improve how well the kidney works after it is transplanted.
This Phase 2 trial studies a treatment using immune cells made from your living donor, given around the time of kidney transplant. It aims to improve transplant safety and outcomes by adjusting the immune response to the new kidney.
This early-phase trial tests a new therapy that uses your own immune cells to reduce your body's attack on a new kidney. It aims to help people who are highly sensitized (hard to match) get a transplant successfully.
This trial tests a combination of low-dose radiation, chemotherapy, and donor immune cells to help your body accept a living donor kidney without long-term anti-rejection drugs.
This trial tests a combined transplant of blood-forming stem cells and a kidney from the same family member. It aims to help people with both advanced kidney failure and a blood cancer by potentially reducing the need for lifelong anti-rejection medicines.
Hear when a new Kidney Transplant Failure and Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.